- Home
- CCG vs GNTA Comparison
CCG vs GNTA Comparison
Compare CCG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- GNTA
- Stock Information
- Founded
- CCG 2014
- GNTA 2014
- Country
- CCG China
- GNTA Italy
- Employees
- CCG N/A
- GNTA N/A
- Industry
- CCG
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCG
- GNTA Health Care
- Exchange
- CCG Nasdaq
- GNTA Nasdaq
- Market Cap
- CCG 63.4M
- GNTA 64.3M
- IPO Year
- CCG N/A
- GNTA 2021
- Fundamental
- Price
- CCG $0.79
- GNTA $3.80
- Analyst Decision
- CCG Buy
- GNTA Strong Buy
- Analyst Count
- CCG 1
- GNTA 1
- Target Price
- CCG $350.00
- GNTA $25.00
- AVG Volume (30 Days)
- CCG 176.1K
- GNTA 7.4K
- Earning Date
- CCG 08-28-2025
- GNTA 01-01-0001
- Dividend Yield
- CCG N/A
- GNTA N/A
- EPS Growth
- CCG N/A
- GNTA N/A
- EPS
- CCG N/A
- GNTA N/A
- Revenue
- CCG $444,290,042.00
- GNTA N/A
- Revenue This Year
- CCG N/A
- GNTA N/A
- Revenue Next Year
- CCG $7.06
- GNTA N/A
- P/E Ratio
- CCG N/A
- GNTA N/A
- Revenue Growth
- CCG 5.20
- GNTA N/A
- 52 Week Low
- CCG $0.56
- GNTA $2.74
- 52 Week High
- CCG $1.54
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- CCG 48.53
- GNTA 54.58
- Support Level
- CCG $0.74
- GNTA $3.33
- Resistance Level
- CCG $0.94
- GNTA $4.50
- Average True Range (ATR)
- CCG 0.05
- GNTA 0.34
- MACD
- CCG 0.00
- GNTA 0.03
- Stochastic Oscillator
- CCG 22.70
- GNTA 47.92
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.